Jichuan Pharmaceutical (600566.SH) subsidiary has obtained a drug registration certificate.

According to the Zhito Finance APP, Jichuan Pharmaceutical (600566.SH) announced that its wholly-owned subsidiary, Jichuan Pharmaceutical Group Co., Ltd. (referred to as "Jichuan Co."), has recently received the drug registration certificates for Pediatric Constipation Granules and Mesalazine Sustained-Release Granules approved and issued by the National Medical Products Administration.